Literature DB >> 2356437

IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.

I S Aaberge1, T E Michaelsen, H E Heier.   

Abstract

Subclasses of IgG antibodies to pneumococcal polysaccharide serotype antigens 4, 6A, and 23F were measured before and 4 weeks after vaccination with pneumococcal vaccine in young individuals splenectomized because of trauma and in a control group. An ELISA technique was applied. IgG2 anti-pneumococcal antibodies predominated before vaccination, especially against serotypes 4 and 6A. The youngest individuals in the splenectomy group tended to have lower IgG2 anti-pneumococcal antibody levels than the older ones. Vaccination induced antibodies of the IgG1 and IgG2 subclasses, and in some individuals also of the IgG4 subclass. Splenectomy does not seem to influence the IgG subclass pattern of antipneumococcal antibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2356437     DOI: 10.1111/j.1365-3083.1990.tb02822.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.

Authors:  M A Shelly; H Jacoby; G J Riley; B T Graves; M Pichichero; J J Treanor
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 2.  Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations.

Authors:  G A Bruyn; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

3.  Effect of non-operative management (NOM) of splenic rupture versus splenectomy on the distribution of peripheral blood lymphocyte populations and cytokine production by T cells.

Authors:  G L Theodorou; A Mouzaki; D Tsiftsis; A Apostolopoulou; A Mougiou; E Theodori; C Vagianos; M Karakantza
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

4.  Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate.

Authors:  C H Lu; C J Lee; P Kind
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

5.  Pneumococcal vaccination responses in adults with subnormal IgG subclass concentrations.

Authors:  Antony R Parker; Markus Skold; Stephen Harding; J Clayborn Barton; Luigi F Bertoli; James C Barton
Journal:  BMC Immunol       Date:  2019-08-20       Impact factor: 3.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.